Autoantibodies against C1q: View on clinical relevance and pathogenic roles

Clinical and Experimental Immunology

Volumn 116, Issue 1, 1999, Pages 04-08

  Siegert, C E H ^f   Kazatchkine, M D ^a   Sjoholm A ^d   Wurzner R ^b   Loos, M ^c   Daha, M R ^e  

^a HÔPITAL BROUSSAIS   (France)

^b UNIVERSITY OF INNSBRUCK   (Austria)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; COMPLEMENT COMPONENT C1Q;

AUTOIMMUNE DISEASE; DISEASE ASSOCIATION; HUMAN; IMMUNOPATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0007981226     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1999.00867.x     Document Type: Review

References (58)

1. 1 Guilbert B, Dighiero G, Avrameas S. Naturally occurring antibodies against nine common antigens in human sera. J Immunol 1982; 128:2779-87.
2. 2 Menzel EJ, Zlabinger GJ, Dunky A, Steffen C. Autoimmunity and T-cell subpopulations in old age. Arch Gerontol Geriatr 1988; 7:249-60.
3. 3 Francoeur A-M, Heitzmann JG. Autoantibodies: terms and concepts. Clin Immunol Immunopathol 1988; 47:245-52.
4. 4 Uwatoko S, Aotsuka S, Okawa M, Egusa Y, Yokohari R, Aizawa C, Suzuki K. Characterization of C1q-binding IgG complexes in systemic lupus erythematosus. Clin Immunol Immunopathol 1984; 30:104-16.
5. 5 Cooper NZ. The classical complement pathway: activation and regulation of the first complement component. Adv Immunol 1985; 37:151-216.
6. 6 Reid KBM, Porter RR. Subunit composition and structure of subcomponent C1q of the first complement of human complement. Biochem J 1976; 155:19-23.
7. 7 Loos M. The classical complement pathway: mechanisms of activation of the first component by antigen-antibody complexes. Proc Allergy 1982; 30:135-92.
8. 8 Schumaker VN, Zavodszky P, Poon PH. Activation of the first component of complement. Ann Rev Immunol 1987; 5:21-42.
9. 9 Hoekzema R, Martes M, Brouwer MC, Hack CE. The distortive mechanism for the activation of complement component C1 supported by studies with a monoclonal antibody against the 'arms' of C1q. Molec Biol 1988; 25:485-94.
10. 10 Schifferli JA, Taylor RP. Physiological and pathological aspects of circulating immune complexes. Kidney Int 1989; 35:993-1003.
11. 11 Turner MW. Mannose-binding lectin: the pluripotent molecule of the innate immune system. Immunol Today 1996; 17:532-40.
12. 12 Hay FC, Nineham LJ, Roitt IM. Routine assay for the detection of immune complexes of known immunoglobulin class using solid phase C1q. Immunol 1976; 24:396-400.
13. 13 Agnello V, Koffler D, Eisenberg JW, Wichester RJ, Kunkel HG. C1q precipitins in the serum of patients with systemic lupus erythematosus and other hypocomplementemic states: characterization of high and low molecular weight types. J Exp Med 1971; 134:228S-241S.
14. 14 Robinson MF, Roberts JL, Verrier Jones J, Lewis EJ. Circulating immune complex assays in patients with lupus and membranous glomerulonephritis. Clin Immunol Immunopathol 1979; 14:348-60.
15. 15 Tung USK, DeHoratius RJ, Williams RC. Study of circulating immune complex size in systemic lupus erythematosus. Clin Exp Immunol 1981; 43:615-25.
16. 16 Hack CE, Belmer AJM. The IgG detected in the C1q solid-phase immune complex assay is not always of immune-complex nature. Clin Immunol Immunopathol 1986; 38:120-8.
17. 17 Wener MH, Mannik M, Schwartz MM, Lewis EJ. Relationship between renal pathology and the size of circulating immune complexes in patients with systemic lupus erythematosus. Med 1987; 66:85-97.
18. 18 Uwatoko S, Mannik M. Low-molecular weight C1q-binding immunoglobulin G in patients with systemic lupus erythematosus consist of autoantibodies to the collagen-like region of C1q. J Clin Invest 1988; 82:816-24.
19. 19 Uwatoko S, Aotsuka S, Okawa M, Egusa Y, Yokohari R, Aizawa C, Suzuki K. C1q solid-phase radioimmunoassay: evidence for detection of antibody directed against the collagen-like region of C1q in sera from patients with systemic lupus erythematosus. Clin Exp Immunol 1987; 69:98-106.
20. 20 Antes U, Heinz H-P, Loos M. Evidence for the presence of autoantibodies to the collagen-like region of C1q in systemic lupus erythematosus. Arthritis Rheum 1988; 31:457-64.
21. 21 Siegert CEH, Daha MR, van der Voort EAM, Breedveld FC. IgG and IgA antibodies to the collagen-like region of C1q in rheumatoid vasculitis. Arthritis Rheum 1990; 33:1646-54.
22. 22 Strife CF, Leahy AE, West CD. Antibody to a cryptic, solid-phase C1q antigen in membranoproliferative nephritis. Kidney Int 1989; 35:836-42.
23. 23 Wener M, Uwatoko S, Mannik M. Antibodies to the collagen-like region of C1q in serum of patients with autoimmune rheumatic diseases. Arthritis Rheum 1989; 32:544-51.
24. 24 Menzel EJ, Scherak O, Kolarz G, Gamerith F, Youngchaiyud U. A method to differentiate between anti-C1q antibodies and C1q-binding immune complexes using collagenase-digested solid-phase C1q. J Immunol Methods 1991; 138:165-77.
25. 25 Rosenberg AM, Prokopchuk PA, Lee JS. The binding of native DNA to the collagen-like segment of C1q. J Rheumatol 1988; 15:1091-6.
26. 26 Agnello V, Mitamura T. Evidence for the detection of low molecular weight DNA - anti-DNA complexes in systemic lupus erythematosus. Arthritis Rheum 1982; 25:788-92.
27. 27 van Schravendijk MR, Dwek RA. Interaction of C1q with DNA. Mol Immunol 1982; 19:1179-87.
28. 28 Uwatoko S, Mannik M. The location of binding sites on C1q for DNA. J Immunol 1990; 144:3484-8.
29. 29 Heinz HP, Brackertz D, Loos M. Enzymatic alteration of C1q, the collagen-like subcomponent of the first component of complement, leads to cross-reactivity with type II collagen. FEBS Letters 1988; 228:332-6.
30. 30 Trinder PKE, Maeurer MJ, Brackertz D, Loos M. The collagen-like component of the complement system, C1q, is recognized by 7S autoantibodies and is functionally impaired in synovial fluids of patients with rheumatoid arthritis. Immunol 1996; 87:355-61.
31. 31 Moreland LW, Gay RE, Gay S. Collagen autoantibodies in patients with vasculitis and systemic lupus erythematosus. Clin Immunol Immunopathol 1991; 60:412-8.
32. 32 Sjöholm AG, Martensson U, Sturfelt G. Serial analysis of autoantibody responses to the collagen-like region of C1q, collagen type II, and double stranded DNA in patients with systemic lupus erythematosus. J Rheumatol 1997; 24:871-8.
33. 33 Mårtensson U, Thiel S, Jensenius JC, Sjöholm AG. Human autoantibodies against C1q: lack of cross-reactivity with the collecting mannan-binding protein, lung surfactant protein A and bovine conglutin. Scan J Immunol 1996; 43:314-20.
34. 34 Siegert CEH, Daha MR, Swaak AJG, van der Voort EAM, Breedveld FC. The relationship between serum liters of autoantibodies against C1q and age in the general population and in patients with systemic lupus erythematosus. Clin Immunol Immunopathol 1993; 67:204-9.
35. 35 Siegert CEH, Daha MR, Halma C, van der Voort EAM, Breedveld FC. IgG and IgA autoantibodies against C1q in systemic and renal diseases. Clin Exp Rheumatol 1992; 10:19-23.
36. 36 Wisnieski JJ, Jones SM. IgG autoantibodies to the collagen-like region of C1q in hypocomplementemic urticarial vasculitis syndrome, systemic lupus erythematosus, and 6 other musculoskeletal or rheumatic diseases. J Rheumatol 1992; 19:884-8.
37. 37 Ravelli A, Wisnieski JJ, Ramenghi B, Ballardini G, Zonta L, Martini A. IgG autoantibodies to complement C1q in pediatric-onset systemic lupus erythematosus. Clin Exp Rheumatol 1997; 15:215-9.
38. 38 Siegert CEH, Daha MR, Westedt ML, van der Voort EAM, Breedveld FC. IgG autoantibodies against C1q are correlated with nephritis, dermatitis, hypocomplementaemia, and dsDNA antibodies in patients with systemic lupus erythematosus. J Rheumatol 1991; 18:230-4.
39. 39 Gunnarsson I, Rönnelid J, Lundberg I, Jacobson H. Occurrence of anti-C1q antibodies in IgA nephropathy. Nephrol Dial Transpl 1997; 12:2263-8.
40. 40 Uwatoko S, Mannik M. IgG subclasses of antibodies to the collagen-like region of C1q in patients with systemic lupus erythematosus. Arthritis Rheum 1989; 32:1601-3.
41. 41 Prada AE, Strife CF. IgG subclass restriction of autoantibody to solid-phase C1q in membranoproliferative and lupus glomerulonephritis. Clin Immunol Immunopathol 1992; 63:84-88.
42. 42 Coremans IEM, Daha MR, van der Voort EAM, Siegert CEH, Breedveld FC. Subclass distribution of IgA and IgG antibodies against C1q in patients with rheumatic diseases. Scand J Immunol 1995; 41:391-7.
43. 43 Haseley LA, Wisnieski JJ, Denburg MR et al. Antibodies to C1q in systemic lupus erythematosus and relation to FcγRIIA alleles. Kidney Int 1997; 52:1375-80.
44. 44 Siegert CEH, Daha MR, Tseng CMES, Coremans IEM, van Es LA, Breedveld FC. Predictive value of IgG autoantibodies against C1q for nephritis in systemic lupus erythematosus. Ann Rheum Dis 1993; 52:851-6.
45. 45 Coremans IEM, Spronk PE, Bootsma H, Daha MR, van der Voort EAM, Kater L, Breedveld FC, Kallenberg CGM. Changes in antibodies to C1q predict renal relapses in systemic lupus erythematosus. Am J Kidney Dis 1995; 26:595-601.
46. 46 Gunnarsson I, Rönnelid J, Huang YH, Rogberg S, Nilsson B, Lundberg I, Klareskog L. Association between ongoing anti-C1q antibody production in peripheral blood and proliferative nephritis in patients with active systemic lupus erythematosus. Br J Rheumtol 1997; 36:32-37.
47. 47 Sjöholm AG, Martensson U, Sturfelt G. Serial analysis of autoantibody responses to the collagen-like region of C1q, collagen type II, and double-stranded DNA in patients with systemic lupus erythematosus. J Rheumatol 1976; 24:871-8.
48. 48 Heinz HP. Biological functions of C1q expressed by conformational changes. Behring Inst Mitt 1989; 84:20-31.
49. 49 Golan MD, Burger R, Loos M. Conformational changes in C1q after binding of immune complexes: detection of neoantigens with monoclonal antibodies. J Immunol 1982; 129:445-7.
50. 50 Couser WG. Mechanisms of glomerular injury in immune-complex diseases. Kidney Int 1985; 28:569-83.
51. 51 Greisman SG, Redechan PB, Kimberley RP, Christian CL. Differences among immune complexes: association of C1q in SLE immune complexes with renal disease. J Immunol 1987; 138:739-45.
52. 52 Wyatt RJ, McAdams AJ, Forristar J, Snyder J, West CD. Glomerular deposition of complement-control proteins in acute and chronic glomerulonephritis. Kidney Int 1979; 16:505-12.
53. 53 Uwatoko S, Gauthier VJ, Mannik M. Autoantibodies to the collagen-like region of C1q deposit in glomeruli via C1q in immune deposits. Clin Immunol Immunopathol 1991; 61:268-73.
54. 54 Coremans IEM, Bruyn JA, de Heer E, van der Voort EAM, Breedveld FC, Daha MR. Stabilization of glomerular deposits of C1q by antibodies against C1q. J Clin Lab Immunol 1995; 44:47-61.
55. 55 Mannik M, Wener MH. Deposition of antibodies to the collagen-like region of C1q in renal glomeruli of patients with proliferative glomerulonephritis. Arthritis Rheum 1997; 40:1504-11.
56. 56 Heinz HP, Burger R, Golan MD, Loos M. Activation of the first component of complement, C1, by a monoclonal antibody recognizing the C chain of C1q. J Immunol 1984; 132:804-8.
57. 57 Frémeaux-Bacchi V, Weiss L, Demouchy C, Blouin J, Kazatchkine MD. Autoantibodies to the collagen-like region of C1q are strongly associated with classical pathway-mediated hypocomplementemia in systemic lupus erythematosus. Lupus 1996; 5:216-20.
58. 58 Siegert CEH, Daha MR, Lobatto S, van der Voort EAM, Breedveld FC. IgG autoantibodies to C1q do not detectably influence complement activation in vivo and in vitro in systemic lupus erythematosus. Immunol Res 1992; 11:91-97.